(0.087 g, 0.20 mmol) in CH2Cl2 (4 mL) was added dropwise.
The mixture was stirred for 2 h at rt. The solvent was removed
on a rotary evaporator, and the residue was purified by silica
gel column chromatography (CH2Cl2 as eluent), followed by
recrystallization from CH2Cl2–hexane to afford crystals of 2a
(0.082 g, 0.14 mmol, 70%), mp 292 ЊC (decomp.); 1H NMR (270
MHz; CDCl3) δ 0.99 (t, J = 7.3 Hz, 3 H), 1.03 (t, J = 7.3 Hz,
3 H), 1.50–1.63 (m, 4 H), 1.71 (s, 6 H), 1.81–1.94 (m, 4 H), 4.14
(t, J = 7.3 Hz, 2 H), 4.29 (t, J = 7.3 Hz, 2 H), 7.03 (d, J = 7.3 Hz,
1 H), 7.16 (d, J = 7.3 Hz, 1 H), 7.26–7.36 (m, 6 H), 7.46 (t,
J = 7.3 Hz, 1 H), 7.64 (d, J = 7.3 Hz, 1 H); IR (KBr) ν 1726,
1722, 1697 cmϪ1; FAB MS m/z 579 ([M ϩ H]ϩ) (Calc. for
C35H34N2O4S: C, 72.64; H, 5.92; N, 4.84. Found: C, 72.90; H,
5.92; N, 4.94%).
(m, 9 H), 1.25–1.67 (m, 10 H), 1.91 (quint, J = 7.9 Hz, 2 H), 3.40
(q, J = 7.9 Hz, 4 H), 4.31 (t, J = 7.9 Hz, 2 H), 6.75 (d, J = 9.2 Hz,
2 H), 7.26–7.38 (m, 3 H), 7.49 (t, J = 7.9 Hz, 1 H), 7.68 (d,
J = 7.3 Hz, 1 H), 8.45 (d, J = 9.2 Hz, 2 H); IR (KBr) ν 1726, 1710
cmϪ1 (C᎐O); FAB MS (m/z) 569 (Mϩ ϩ H, 100%), 568 (Mϩ, 97)
᎐
(Calc. for C34H36N2O4S ϩ 0.2H2O: C, 71.35; H, 6.41; N, 4.89.
Found: C, 71.28; H, 6.43; N, 4.83%).
3-[4-(Dibutylamino)phenyl]-3Ј-(1-butyl-1,2-dihydroquinolin-
2-ylidenemethyl)-4,4Ј-bis(cyclobut-3-ene-1,2-dione) 2g. Yield
30%; mp 250 ЊC (decomp.); 1H NMR (CDCl3) δ 0.98 (t, J = 7.3
Hz, 3 H), 1.11 (t, J = 7.3 Hz, 6 H), 1.21–1.76 (m, 12 H), 3.36
(q, J = 7.3 Hz, 4 H), 4.47 (t, J = 7.3 Hz, 2 H), 6.75 (d, J = 9.2 Hz,
2 H), 7.09 (s, vinyl H, 1 H), 7.47 (t, J = 7.3 Hz, 1 H), 7.61–7.74
(m, 3 H), 7.82 (d, J = 9.8 Hz, 1 H), 8.39 (d, J = 9.2 Hz, 2 H), 8.91
Unsymmetrical bisquaraine dyes 2b–i were prepared by the
general procedure outlined for 2a.
(d, J = 9.8 Hz, 1 H); IR (KBr) ν 1733, 1714 cmϪ1 (C᎐O);
᎐
FAB MS (m/z) 563 (Mϩ ϩ H, 100%), 562 (Mϩ, 74) (Calc. for
C36H38N2O4 ϩ 0.75H2O: C, 75.04; H, 6.91; N, 4.86. Found: C,
75.10; H, 6.77; N, 4.69%).
3-(1-Butyl-3,3-dimethylindolin-2-ylidenemethyl)-3Ј-(1-butyl-1,2-
dihydroquinolin-2-ylidenemethyl)-4,4Ј-bis(cyclobut-3-ene-1,2-
dione) 2b
3-(2,3,6,7-Tetrahydro-1H,5H-pyrido[3,2,1-ij]quinolin-9-yl)-
3Ј-(3-butyl-2,3-dihydrobenzothiazol-2-ylidenemethyl)-4,4Ј-bis-
(cyclobut-3-ene-1,2-dione) 2h. Yield 35%; 1H NMR (CDCl3)
δ 1.06 (t, J = 7.3 Hz, 3 H), 1.52–2.23 (m, 8 H), 2.81 (quint,
J = 6.2 Hz, 4 H), 3.36 (t, J = 6.7 Hz, 4 H), 4.30 (t, J = 7.3 Hz,
2 H), 7.26–7.38 (m, 2 H), 7.45 (m, 2 H), 7.66 (d, J = 7.9 Hz,
Yield 50%; mp 283 ЊC (decomp.); 1H NMR (270 MHz; CDCl3)
δ 0.99 (t, J = 7.3 Hz, 3 H), 1.10 (t, J = 7.3 Hz, 3 H), 1.48–1.66 (m,
4 H), 1.71 (s, 6 H), 1.76–1.95 (m, 4 H), 4.15 (t, J = 7.3 Hz, 2 H),
4.46 (t, J = 7.3 Hz, 2 H), 7.03 (d, J = 7.3 Hz, 1 H), 7.16 (d, J = 7.3
Hz, 1 H), 7.26–7.42 (m, 5 H), 7.57–7.75 (m, 4 H), 8.90 (d, J = 9.8
Hz, 1 H); IR (KBr) ν 1724, 1718, 1699 cmϪ1; FAB MS m/z 573
([M ϩ H]ϩ) (Calc. for C37H36N2O4: C, 77.60; H, 6.34; N, 4.89.
Found: C, 77.84; H, 6.39; N, 4.98%).
1 H), 8.07 (s, 2 H); IR (KBr) ν 1709, 1687 cmϪ1 (C᎐O); FAB MS
᎐
(m/z) 537 (Mϩ ϩ H, 28%), 536 (Mϩ, 30) (Calc. for C32H28-
N2O4S: C, 71.62; H, 5.25; N, 5.22. Found: C, 71.45; H, 5.30;
N, 5.04%).
3-(1-Butyl-3,3-dimethylindolin-2-ylidenemethyl)-3Ј-(1-butyl-1,4-
dihydroquinolin-4-ylidenemethyl)-4,4Ј-bi(cyclobut-3-ene-1,2-
dione) 2c
3-(2,3,6,7-Tetrahydro-1H,5H-pyrido[3,2,1-ij]quinolin-9-yl)-
3Ј-(1-butyl-1,2-dihydroquinolin-2-ylidenemethyl)-4,4Ј-bis(cyclo-
1
1
but-3-ene-1,2-dione) 2i. Yield 30%; mp 320 ЊC (decomp.); H
Yield 50%; mp 274 ЊC; H NMR (270 MHz; CDCl3) δ 0.99 (t,
NMR (CDCl3) δ 1.10 (t, J = 7.3 Hz, 3 H), 1.52–1.88 (m, 2 H),
1.92–2.20 (m, 6 H), 2.81 (quint, J = 6.1 Hz, 4 H), 3.37 (t, J =
6.1 Hz, 4 H), 4.47 (t, J = 7.9 Hz, 2 H), 7.10 (s, vinyl H, 1 H),
7.39–7.70 (m, 4 H), 7.79 (d, J = 9.7 Hz, 2 H), 8.01 (s, 2 H),
J = 7.3 Hz, 3 H), 1.01 (t, J = 7.3 Hz, 3 H), 1.41–1.60 (m, 4 H),
1.72 (s, 6 H), 1.82–1.92 (m, 4 H), 4.15 (t, J = 7.3 Hz, 2 H), 4.24
(t, J = 7.3 Hz, 2 H), 7.02 (d, J = 7.3 Hz, 1 H), 7.15 (d, J = 7.3 Hz,
1 H), 7.29–7.37 (m, 3 H), 7.52–7.61 (m, 3 H), 7.74 (m, 1 H), 7.85
(s, 1 H), 8.47 (d, J = 7.3 Hz, 1 H), 8.64 (dd, J = 1.2 and 8.6 Hz,
1 H); IR (KBr) ν 1724, 1697 cmϪ1; FAB MS m/z 573 ([M ϩ H]ϩ)
(Calc. for C37H36N2O4: C, 77.60; H, 6.34; N, 4.89. Found:
C, 77.34; H, 6.31; N, 4.89%).
8.91 (d, J = 9.7 Hz, 1 H); IR (KBr) ν 1730, 1713 cmϪ1 (C᎐O);
᎐
FAB MS (m/z) 532 (Mϩ ϩ H, 26%), 531 (Mϩ, 43) (Calc. for
C34H30N2O4 ϩ 0.2H2O: C, 76.44; H, 5.74; N, 5.24%. Found: C,
76.38; H, 5.63; N, 5.28%).
X-Ray crystallographic analysis of 1a
3-[4-(Diethylamino)phenyl]-3Ј-(3-butyl-2,3-dihydrobenzo-
thiazol-2-ylidenemethyl)-4,4Ј-bis(cyclobut-3-ene-1,2-dione) 2d.
Yield 38%; mp 252 ЊC (decomp.); H NMR (CDCl3) δ 1.04 (t,
A single crystal of 1a suitable for X-ray crystallography was
obtained by recrystallization from a CH2Cl2 solution of 1a
in hexane by slow solvent diffusion. All reflection data were
collected on a Rigaku AFC5-R diffractometer using graphite-
monochromated Mo-Kα radiation. Intensity data were
collected in the range of 3 < 2θ < 55Њ using an ω–2θ scan
technique. The structure was solved by a direct method and
refined by a full matrix least-square procedure. The reflections
with I > 4σ(I ) were used for the structure refinement. All non-
hydrogen atoms, except C(9), were refined with anisotropic
thermal parameters. All hydrogen atoms were placed at the
calculated positions, and subsequently included in the structure
refinement. For the refinement, the TEXSAN program was
used. Tables of the atomic coordinates, isotropic thermal
parameters, full lists of bond lengths and angles, and least-
squares planes have been deposited in supplementary Tables.
Crystal data: C38H40N2O4, M 588.74, triclinic, space group
P-1, cell constants: a = 10.933(3), b = 17.941(5), c = 8.474(2) Å,
α = 92.31(3)Њ, β = 102.96(3)Њ, γ = 81.59(2)Њ, V = 1602.3(7) Å3, Z =
2, Dcalc = 1.220 g cmϪ3, unique reflections 4263, final R = 0.083,
Rw = 0.089.†
1
J = 7.3 Hz, 3 H), 1.45–1.64 (m, 2 H), 1.25 (t, J = 7.3 Hz, 6 H),
1.92 (quint, J = 7.3 Hz, 2 H), 3.50 (q, J = 7.3 Hz, 4 H), 4.31 (t,
J = 7.9 Hz, 2 H), 6.78 (t, J = 9.2 Hz, 2 H), 7.26–7.38 (m, 3 H),
7.49 (t, J = 7.9 Hz, 1 H), 7.68 (d, J = 7.9 Hz, 1 H), 8.46 (d, J = 9.2
Hz, 2 H); IR (KBr) ν 1738, 1733 cmϪ1 (C᎐O); FAB MS (m/z),
᎐
513 (Mϩ ϩ H, 100%), 512 (Mϩ, 69) (Calc. for C30H28N2O4S:
C, 70.29; H, 5.51; N, 5.46. Found: C, 69.99; H, 5.49; N, 5.30%).
3-[4-(Diethylamino)phenyl]-3Ј-(1-butyl-1,2-dihydroquinolin-2-
ylidenemethyl)-4,4Ј-bis(cyclobut-3-ene-1,2-dione) 2e. Yield 70%;
1
mp 248 ЊC (decomp.); H NMR (CDCl3) δ 1.10 (t, J = 7.3 Hz,
3 H), 1.25 (t, J = 7.3 Hz, 6 H), 1.70–1.99 (m, 4 H), 3.49 (q,
J = 7.3 Hz, 4 H), 4.48 (t, J = 7.9 Hz, 2 H), 6.77 (d, J = 9.2 Hz,
2 H), 7.09 (s, vinyl H, 1 H), 7.47 (t, J = 6.7 Hz, 1 H), 7.61–7.71
(m, 3 H), 7.82 (d, J = 9.2 Hz, 1 H), 8.40 (d, J = 9.2 Hz, 2 H), 8.91
(d, J = 9.2 Hz, 1 H); IR (KBr) ν 1738, 1732 cmϪ1 (C᎐O);
᎐
FAB MS (m/z) 507 (Mϩ ϩ H, 100%), 506 (Mϩ, 52) (Calc. for
C32H30N2O4: C, 75.86; H, 5.97; N, 5.53. Found: C, 74.94; H,
5.71; N, 5.43%).
3-[4-(Dibutylamino)phenyl]-3Ј-(3-butyl-2,3-dihydrobenzo-
thiazol-2-ylidenemethyl)-4,4Ј-bis(cyclobut-3-ene-1,2-dione) 2f.
Yield 33%; mp 257 ЊC (decomp.); 1H NMR (CDCl3) δ 1.86–0.06
p1/b1/b104059f/ for crystallographic files in .cif or other electronic
format.
J. Chem. Soc., Perkin Trans. 1, 2001, 2823–2830
2829